Jiangxi Jinfeng Pharmaceutical Co., Ltd.

Jiangxi Jinfeng Pharmaceutical Co., Ltd., a manufacturer of pharmaceutical intermediates and APIs located on the 19th Industry Road in the Yanshan County industrial park in Shangrao, Jiangxi Province, China, covers a total area of 52,000 square meters with total investment exceeding one billion RMB, including nearly twenty million RMB dedicated to treatment of the 'three wastes'. Equipped with advanced manufacturing facilities, a rigorous quality control system and an excellent R&D team, and having strictly implemented GMP and ISO 9001 standards with EU-GMP approval since March 2018, the company specializes in producing the Lutamide series (Bicalutamide, Enzalutamide, Apalutamide and Darolutamide), plus Pregabalin, Mirogabalin, Midazolam, Lurasidone, Tolvaptan and Conivaptan intermediates, among others.